-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FyPN64aPTB/6MF+F1IMvSYhBwDEdJMJfUuEj2mJba5zagF4+Asf0M1/6u7QVYSlr fOrP7yejar/WjfLOj6azcA== 0001209191-05-020198.txt : 20050411 0001209191-05-020198.hdr.sgml : 20050411 20050411152309 ACCESSION NUMBER: 0001209191-05-020198 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050407 FILED AS OF DATE: 20050411 DATE AS OF CHANGE: 20050411 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: UPRICHARD DAVID C CENTRAL INDEX KEY: 0001239916 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23736 FILM NUMBER: 05743934 MAIL ADDRESS: STREET 1: 12 PINE STREET CITY: PHILADELPHIA STATE: PA ZIP: 19106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GUILFORD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000918066 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521841960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6611 TRIBUTARY ST CITY: BALTIMORE STATE: MD ZIP: 21224 BUSINESS PHONE: 4106316300 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2005-04-07 0 0000918066 GUILFORD PHARMACEUTICALS INC GLFD 0001239916 UPRICHARD DAVID C 12 PINE STREET PHILADELPHIA PA 19106 1 0 0 0 Common Stock 2005-04-07 4 P 0 2000 2.24 A 2000 D Restricted Stock Units 0.00 Common Stock 4239 8158 D Stock Options (Right to buy) 6.62 2004-11-18 2013-11-18 Common Stock 30000 30000 D The Restricted Stock Units will be exchanged for shares of the Company's common stock six months after termination of Mr. U'Prichard's service with the Company's Board of Directors. Asher M. Rubin, Attorney-in-fact 2005-04-11 -----END PRIVACY-ENHANCED MESSAGE-----